Cytobull 50 BULL PHARMA

£78.00

Cytobull 50 from BULL PHARMA is a trenbolone acetate injectable research compound formulated for in-vitro laboratory investigation of androgenic mechanisms and steroid pharmacology.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Cytobull 50 BULL PHARMA
Cytobull 50 BULL PHARMA
£78.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview of Cytobull 50

Cytobull 50 is a trenbolone acetate injectable formulation manufactured by BULL PHARMA specifically for controlled laboratory research applications. Trenbolone acetate is a potent synthetic anabolic-androgenic steroid derived from nandrolone, characterised by its unique triple-bond structure that confers exceptional androgenic receptor binding affinity. Research scientists investigating steroid pharmacokinetics and androgenic pathway modulation can examine this compound’s molecular interactions within cellular models. The acetate ester attachment provides researchers with predictable pharmacokinetic properties suitable for controlled experimental protocols. This formulation enables comprehensive studies of androgenic receptor activation, protein synthesis pathways, and anabolic signalling cascades in laboratory environments.

Laboratory Applications

Research teams at Stroid UK Shop utilise Cytobull 50 to investigate multiple aspects of androgenic steroid biology. Scientists examine how trenbolone acetate interacts with androgen receptors at the molecular level, studying binding kinetics and downstream transcriptional effects. The compound serves as a valuable research tool for analysing anabolic signalling pathways, protein synthesis mechanisms, and cellular response patterns. Comparative studies often evaluate trenbolone acetate alongside other trenbolone compounds to understand structural variations in androgenic potency. Research applications extend to investigating metabolic pathways, enzyme interactions, and tissue-specific responses in controlled laboratory settings. Advanced research protocols examine the compound’s interaction with various cellular models, providing insights into androgenic steroid mechanisms that complement studies involving SARMs and peptide research compounds.

Technical Specifications

Cytobull 50 Research Compound Specifications
Parameter Specification
Active Compound Trenbolone Acetate
Concentration 50mg/ml
Manufacturer BULL PHARMA
Formulation Injectable Solution
CAS Number 10161-34-9
Molecular Formula C₂₀H₂₄O₃
Molecular Weight 312.4 g/mol
Storage Requirements Room temperature, protect from light

Research Compliance Statement

Cytobull 50 trenbolone acetate is manufactured exclusively for in-vitro research purposes and controlled laboratory investigations. This compound is not intended for human consumption, therapeutic applications, or any use outside of qualified research facilities. Research institutions must maintain appropriate handling protocols, safety documentation, and regulatory compliance when studying this androgenic steroid compound. All experimental work should be conducted by qualified researchers following established laboratory safety guidelines and institutional protocols for anabolic steroid research materials.

Related